All pre-diabetes is not the same: Metabolic and vascular risks of impaired fasting glucose at 100 versus 110 mg/dl - The screening for impaired glucose tolerance study 1 (SIGT 1)

被引：21
|
作者：
Phillips, Lawrence S.
Weintraub, William S.
Ziemer, David C.
Kolm, Paul
Foster, Jovonne K.
Vaccarino, Viola
Rhee, Mary K.
Budhwani, Rahim K.
Caudle, Jane M.
机构：
[1] Emory Univ, Sch Med, Div Endocrinol & Metab, Dept Med, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA USA
来源：
DIABETES CARE | 2006年 / 29卷 / 06期
关键词：
D O I：
10.2337/dc06-0242
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1405 / 1407
页数：3
相关论文
共 50 条
  • [21] Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study
    Laakso, M.
    Zilinskaite, J.
    Hansen, T.
    Boesgaard, T. Wellov
    Vanttinen, M.
    Stancakova, A.
    Jansson, P. -A.
    Pellme, F.
    Holst, J. J.
    Kuulasmaa, T.
    Hribal, M. L.
    Sesti, G.
    Stefan, N.
    Fritsche, A.
    Haring, H.
    Pedersen, O.
    Smith, U.
    DIABETOLOGIA, 2008, 51 (03) : 502 - 511
  • [22] Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study
    M. Laakso
    J. Zilinskaite
    T. Hansen
    T. Welløv Boesgaard
    M. Vänttinen
    A. Stančáková
    P.-A. Jansson
    F. Pellmé
    J. J. Holst
    T. Kuulasmaa
    M. L. Hribal
    G. Sesti
    N. Stefan
    A. Fritsche
    H. Häring
    O. Pedersen
    U. Smith
    Diabetologia, 2008, 51 : 502 - 511
  • [23] Screening for pre-diabetes to predict future diabetes using various cut-off points for HbA1c and impaired fasting glucose: the Toranomon Hospital Health Management Center Study 4 (TOPICS 4)
    Heianza, Y.
    Arase, Y.
    Fujihara, K.
    Tsuji, H.
    Saito, K.
    Hsieh, S. D.
    Kodama, S.
    Shimano, H.
    Yamada, N.
    Hara, S.
    Sone, H.
    DIABETIC MEDICINE, 2012, 29 (09) : E279 - E285
  • [24] A CROSS-SECTIONAL STUDY OF THE ASSOCIATION BETWEEN THE 1-HOUR ORAL GLUCOSE TOLERANCE TEST AND THE METABOLIC SYNDROME IN A HIGH-RISK SAMPLE WITH IMPAIRED FASTING GLUCOSE
    Lizarzaburu-Robles, Juan Carlos
    Torres-Aparcana, Lizardo
    Mansilla, Raul
    Valera, Jose
    Vargas, Gabriela
    Vento, Flor
    Laca, Jose
    Cornetero, Victor
    Herman, William H.
    ENDOCRINE PRACTICE, 2020, 26 (05) : 529 - 534
  • [25] Hemoglobin A1c in combination with fasting plasma glucose trumps fasting plasma glucose alone as predictive indicators for diabetes mellitus: an ambidirectional cohort study of Thai people with impaired fasting glucose
    Thamakaison, Sangsulee
    Anothaisintawee, Thunyarat
    Sukhato, Kanokporn
    Unwanatham, Nattawut
    Rattanasiri, Sasivimol
    Reutrakul, Sirimon
    Thakkinstian, Ammarin
    BMJ OPEN DIABETES RESEARCH & CARE, 2021, 9 (02)
  • [26] Both Vascular Endothelial Growth Factor and Soluble Flt-1 Are Increased in Type 2 Diabetes But Not in Impaired Fasting Glucose
    Nandy, Debashis
    Mukhopadhyay, Debabrata
    Basu, Ananda
    JOURNAL OF INVESTIGATIVE MEDICINE, 2010, 58 (06) : 804 - 806
  • [27] Use of glycated hemoglobin (HbA1c) and impaired glucose tolerance in the screening of undiagnosed diabetes in the Malaysian population
    Qvist R.
    Ismail I.S.
    Chinna K.
    Muniandy S.
    Indian Journal of Clinical Biochemistry, 2008, 23 (3) : 246 - 249
  • [28] Impaired fasting glucose has advantages in predicting Type 2 diabetes compared to impaired glucose tolerance when combined with BMI and HbA1c: a Swedish population based incident case-referent study
    Norberg, M
    Eriksson, JW
    Lindahl, B
    Andersson, C
    Rolandsson, O
    Stenlund, H
    Weinehall, L
    DIABETOLOGIA, 2004, 47 : A144 - A144
  • [29] HbA1c in diagnosing and predicting Type 2 diabetes in impaired glucose tolerance: the Finnish Diabetes Prevention Study
    Pajunen, P.
    Peltonen, M.
    Eriksson, J. G.
    Ilanne-Parikka, P.
    Aunola, S.
    Keinanen-Kiukaanniemi, S.
    Uusitupa, M.
    Tuomilehto, J.
    Lindstrom, J.
    DIABETIC MEDICINE, 2011, 28 (01) : 36 - 42
  • [30] Toward targeted prevention: risk factors for prediabetes defined by impaired fasting glucose, impaired glucose tolerance and increased HbA1c in the population-based KORA study from Germany
    Gregory G. Greiner
    Karl M. F. Emmert-Fees
    Jana Becker
    Wolfgang Rathmann
    Barbara Thorand
    Annette Peters
    Anne S. Quante
    Lars Schwettmann
    Michael Laxy
    Acta Diabetologica, 2020, 57 : 1481 - 1491
12345